F Gallardo Selected Research

F Gallardo Research Topics

4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 03/2009
4	Lymphoma (Lymphomas) 01/2018 - 01/2000
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2018 - 01/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2012 - 01/2006
1	Tuberculosis (Tuberculoses) 01/2022
1	Psoriatic Arthritis 03/2019
1	Mycosis Fungoides 03/2018
1	Pruritus (Itching) 01/2018
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 06/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2009
1	Neoplasms (Cancer) 10/2008
1	Vulvodynia 01/2008
1	Prostatitis 01/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2005
1	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2005
1	Intrahepatic Cholestasis 08/2003
1	Cholestasis 08/2003
1	Lymphadenopathy 01/2003
1	Pathologic Complete Response 01/2000
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2000

2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2018 - 10/2008
1	ixekizumabIBA 03/2019
1	Aprepitant (Emend)FDA Link 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 11/2016
1	Imiquimod (Aldara)FDA LinkGeneric 06/2014
1	Rituximab (Mabthera)FDA Link 07/2012
1	Infliximab (Remicade)FDA Link 03/2009
1	Monoclonal AntibodiesIBA 03/2009
1	Biological ProductsIBA 03/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	Immunoglobulins (Immunoglobulin)IBA 10/2008
1	Antidepressive Agents (Antidepressants)IBA 01/2008
1	AndrogensIBA 01/2007
1	Progesterone FDA LinkGeneric 01/2007
1	Estrogen Receptor alphaIBA 01/2007
1	Estrogen Receptor betaIBA 01/2007
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2005
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 08/2003
1	Thallium-201IBA 01/2000
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2000
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2000
1	CholesterolIBA 01/2000

2	Drug Therapy (Chemotherapy) 01/2016 - 10/2005
2	Therapeutics 01/2003 - 01/2000
1	Biological Therapy 01/2022
1	Radiotherapy 06/2014
1	Lasers (Laser) 01/2006
1	Highly Active Antiretroviral Therapy (HAART) 10/2005